Class information for:
Level 1: THROMBOXANE A2 RECEPTOR//THROMBOXANE RECEPTOR//THROMBOXANE A2

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
4550 1693 32.5 66%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
670 12541 CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 THROMBOXANE A2 RECEPTOR Author keyword 54 64% 3% 53
2 THROMBOXANE RECEPTOR Author keyword 26 52% 2% 35
3 THROMBOXANE A2 Author keyword 25 17% 8% 138
4 S 1452 Author keyword 21 85% 1% 11
5 THROMBOXANE A2 RECEPTOR ANTAGONISTS Author keyword 12 86% 0% 6
6 PICOTAMIDE Author keyword 12 59% 1% 13
7 THROMBOXANE A2 RECEPTORS Author keyword 11 67% 1% 10
8 THROMBOXANE RECEPTOR ANTAGONIST Author keyword 10 47% 1% 16
9 THROMBOXANE ANTAGONISTS Author keyword 10 63% 1% 10
10 THROMBOXANE A2 RECEPTOR ANTAGONIST Author keyword 9 47% 1% 14

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 THROMBOXANE A2 RECEPTOR 54 64% 3% 53 Search THROMBOXANE+A2+RECEPTOR Search THROMBOXANE+A2+RECEPTOR
2 THROMBOXANE RECEPTOR 26 52% 2% 35 Search THROMBOXANE+RECEPTOR Search THROMBOXANE+RECEPTOR
3 THROMBOXANE A2 25 17% 8% 138 Search THROMBOXANE+A2 Search THROMBOXANE+A2
4 S 1452 21 85% 1% 11 Search S+1452 Search S+1452
5 THROMBOXANE A2 RECEPTOR ANTAGONISTS 12 86% 0% 6 Search THROMBOXANE+A2++RECEPTOR+ANTAGONISTS Search THROMBOXANE+A2++RECEPTOR+ANTAGONISTS
6 PICOTAMIDE 12 59% 1% 13 Search PICOTAMIDE Search PICOTAMIDE
7 THROMBOXANE A2 RECEPTORS 11 67% 1% 10 Search THROMBOXANE+A2+RECEPTORS Search THROMBOXANE+A2+RECEPTORS
8 THROMBOXANE RECEPTOR ANTAGONIST 10 47% 1% 16 Search THROMBOXANE+RECEPTOR+ANTAGONIST Search THROMBOXANE+RECEPTOR+ANTAGONIST
9 THROMBOXANE ANTAGONISTS 10 63% 1% 10 Search THROMBOXANE+ANTAGONISTS Search THROMBOXANE+ANTAGONISTS
10 THROMBOXANE A2 RECEPTOR ANTAGONIST 9 47% 1% 14 Search THROMBOXANE+A2+RECEPTOR+ANTAGONIST Search THROMBOXANE+A2+RECEPTOR+ANTAGONIST

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 A2 RECEPTOR 39 46% 4% 64
2 ENDOPEROXIDE RECEPTOR 27 92% 1% 11
3 TP ALPHA 23 79% 1% 15
4 SQ 29 548 23 65% 1% 22
5 AA 2414 21 90% 1% 9
6 SYNTHETASE INHIBITOR 20 33% 3% 49
7 PROSTAGLANDIN H2 RECEPTORS 18 89% 0% 8
8 S 145 18 89% 0% 8
9 PROSTAGLANDIN ENDOPEROXIDES 16 18% 5% 81
10 13 AZAPROSTANOIC ACID 15 82% 1% 9

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Thromboxane A(2): Physiology/pathophysiology, cellular signal transduction and pharmacology 2008 144 194 64%
Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation 2014 8 96 38%
Thromboxane A(2) Receptor: Biology and Function of a Peculiar Receptor that Remains Resistant for Therapeutic Targeting 2012 7 123 54%
From the design to the clinical application of thromboxane modulators 2006 36 242 48%
Thromboxane A(2) and related prostaglandins in airways 1997 49 155 47%
The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis 2011 22 99 44%
Cell signalling through thromboxane A(2) receptors 2004 93 194 44%
Prostanoid and TP-receptors in atherothrombosis Is there a role for their antagonism? 2010 21 58 43%
Therapeutic potential of thromboxane inhibitors in asthma 2002 22 72 68%
Thromboxanes: Synthase and receptors 1998 54 163 49%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 INFLAMMAT PHARMACOL S 3 38% 0.4% 6
2 CELL MOLEC PHARMACOL EXPTL THER EUT 2 67% 0.1% 2
3 NAT SYNTH DRUG 2 40% 0.2% 4
4 171 ASHLEY AVE 1 50% 0.1% 2
5 EXPT HEMODYNAM HEMOLIEGE 1 100% 0.1% 2
6 KLINIKUM MANNHEIM CLIN CHEM 1 100% 0.1% 2
7 PHARMACOL 171 ASHLEY AVE 1 50% 0.1% 2
8 PMS PLANNING DEV GRP 1 100% 0.1% 2
9 POB 1005 1 100% 0.1% 2
10 NAT SYNTHET DRUG 1 27% 0.2% 4

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000221732 EXPT THER EUT PHARMACOINFORMAT//PROSTACYCLIN SYNTHASE GENE//PROSTACYCLIN SYNTHASE
2 0.0000157001 ILOPROST//WESTERN INFIRM SURG//TAPROSTENE
3 0.0000124276 ONO 1301//IP RECEPTOR//EP4 RECEPTOR
4 0.0000101025 9 ALLYLPURINES//ANTIPLATELET COMPOUNDS//HAMILTON GEN HOSP CLIN UNIT
5 0.0000078531 MED BIOCHEM KURAMOTO CHO//4 ACETOXY 2 4 METHYLPHENYLBENZOTHIAZOLE//PHARMACEUT S KITA KU
6 0.0000076012 ENDOTHELIUM DEPENDENT CONTRACTIONS//ENDOTHELIUM DEPENDENT CONTRACTION//ENDOTHELIUM DERIVED CONTRACTING FACTOR
7 0.0000074746 HUMAN PLATELET//PLATELETS HUMAN//ATPASE CA2 MG2
8 0.0000065233 CARBACYCLIN//CARBACYCLINS//SM 10906
9 0.0000062273 CRTH2//MOL BEHAV BIOL//PROSTAGLANDIN D 2
10 0.0000060050 AGGREGATED PROTEIN//IMMUNOGLOBULIN G COMPLEXES//MESANGIUM